Technical Analysis for VXRT - Vaxart, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.02 | 7.98% | 0.08 |
VXRT closed up 7.98 percent on Thursday, May 16, 2024, on 1.94 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Stochastic Reached Overbought | Strength | 7.98% | |
| Weak + Overbought | Other | 7.98% |
| Alert | Time |
|---|---|
| Possible Pocket Pivot | about 5 hours ago |
| Gap Up Closed | about 7 hours ago |
| Reversed from Up | about 7 hours ago |
| 60 Minute Opening Range Breakdown | about 7 hours ago |
| 50 DMA Resistance | about 7 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Vaccines Influenza Coronavirus Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Vaccine Preventable Diseases Human Papilloma Virus Human Papillomavirus Infection
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Vaccines Influenza Coronavirus Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Vaccine Preventable Diseases Human Papilloma Virus Human Papillomavirus Infection
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.54 |
| 52 Week Low | 0.53 |
| Average Volume | 1,636,075 |
| 200-Day Moving Average | 0.84 |
| 50-Day Moving Average | 0.98 |
| 20-Day Moving Average | 0.76 |
| 10-Day Moving Average | 0.80 |
| Average True Range | 0.08 |
| RSI (14) | 65.87 |
| ADX | 33.48 |
| +DI | 33.01 |
| -DI | 15.26 |
| Chandelier Exit (Long, 3 ATRs) | 0.82 |
| Chandelier Exit (Short, 3 ATRs) | 0.87 |
| Upper Bollinger Bands | 0.93 |
| Lower Bollinger Band | 0.59 |
| Percent B (%b) | 1.25 |
| BandWidth | 44.72 |
| MACD Line | -0.02 |
| MACD Signal Line | -0.06 |
| MACD Histogram | 0.045 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.20 | ||||
| Resistance 3 (R3) | 1.19 | 1.13 | 1.17 | ||
| Resistance 2 (R2) | 1.13 | 1.08 | 1.13 | 1.16 | |
| Resistance 1 (R1) | 1.07 | 1.05 | 1.10 | 1.08 | 1.15 |
| Pivot Point | 1.01 | 1.01 | 1.02 | 1.01 | 1.01 |
| Support 1 (S1) | 0.95 | 0.96 | 0.98 | 0.96 | 0.89 |
| Support 2 (S2) | 0.89 | 0.93 | 0.89 | 0.88 | |
| Support 3 (S3) | 0.83 | 0.89 | 0.87 | ||
| Support 4 (S4) | 0.84 |
